PGNYProgyny, Inc.

Nasdaq progyny.com


$ 28.16 $ -0.20 (-0.71 %)    

Tuesday, 02-Jul-2024 13:03:20 EDT
QQQ $ 484.34 $ 4.45 (0.93 %)
DIA $ 391.04 $ 0.20 (0.05 %)
SPY $ 546.34 $ 2.60 (0.48 %)
TLT $ 90.13 $ -0.54 (-0.6 %)
GLD $ 214.82 $ -0.46 (-0.21 %)
$ 28.38
$ 28.36
$ 0.00 x 0
$ 0.00 x 0
$ 28.01 - $ 28.45
$ 23.90 - $ 44.95
1,243,542
na
2.87B
$ 1.31
$ 46.82
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-10-2020 12-31-2019 10-K
19 12-06-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 progyny-reports-acquisition-of-berlin-based-fertility-benefits-platform-apryl-no-terms-disclosed

This acquisition enhances Progyny's guided, concierge support that enables employees around the world to navigate the compl...

 truist-securities-maintains-buy-on-progyny-lowers-price-target-to-37

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $46 to...

 cantor-fitzgerald-reiterates-overweight-on-progyny-maintains-48-price-target

Cantor Fitzgerald analyst Sarah James reiterates Progyny (NASDAQ:PGNY) with a Overweight and maintains $48 price target.

 barclays-maintains-overweight-on-progyny-lowers-price-target-to-30

Barclays analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $48 to $30.

 canaccord-genuity-maintains-buy-on-progyny-lowers-price-target-to-37

Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $46 to $37.

 fertility-solutions-focused-progyny-stock-sinks-after-soft-guidance-analyst-says-can-no-longer-underwrite-sustained-healthy-growth-in-forecasts

Progyny reported first-quarter sales of $278.1 million, slightly below expectations due to increased clients and covered lives....

 btig-maintains-buy-on-progyny-lowers-price-target-to-41

BTIG analyst David Larsen maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $50 to $41.

 keybanc-downgrades-progyny-to-sector-weight

Keybanc analyst Scott Schoenhaus downgrades Progyny (NASDAQ:PGNY) from Overweight to Sector Weight.

 progyny-q1-2024-adj-eps-039-beats-013-estimate-sales-278078m-miss-289457m-estimate

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.13 by 200 ...

 truist-securities-reiterates-buy-on-progyny-maintains-46-price-target

Truist Securities analyst Jailendra Singh reiterates Progyny (NASDAQ:PGNY) with a Buy and maintains $46 price target.